Is the endogenous digitalis-like factor the link between hypertension and metabolic disorders as diabetes mellitus, obesity and acromegaly?
Endogenous factors cross-reacting with antidigoxin antibodies have been found in several tissues and body fluids of animals and humans, using commercially available digoxin radioimmunoassay or enzyme immunoassay methods. The chemical characteristics of these endogenous factors are, at present, unknown, although it has been suggested that they could be substances with low molecular weight. Experimental studies and theoretical considerations indicate that endogenous digitalis-like factors (DDLFs), in addition to the ability to react with antibodies, might also bind to the specific cellular receptor of the cardiac glycosides and thus inhibit the membrane Na+/K(+)-ATPase (sodium pump). Therefore, EDLF can be an endogenous modulator of the membrane sodium-potassium pump and several authors have suggested that EDLF could play a role in the regulation of fluids and electrolytes, muscular tone of myocardial and also in the pathogenesis of arterial hypertension. In this review, the authors discuss the hypothesis that, in metabolic diseases such as diabetes mellitus, obesity and acromegaly, the sodium retention and volume expansion, possibly due to exaggerated sodium intake, and/or exogenously induced peripheral hyperinsulinemia and high levels of growth hormone, could trigger a sustained release of EDLF, which in turn increases the blood pressure.
Clerico
A
A
Istituto di Fisiologia Clinica del CNR, Università di Pisa, Italy.
Giampietro
O
O
D000172:Acromegaly / Q000503:physiopathology*; D001798:Blood Proteins / Q000032:analysis / Q000502:physiology*; D002298:Cardenolides; D002301:Cardiac Glycosides / Q000032:analysis / Q000378:metabolism; D003920:Diabetes Mellitus / Q000503:physiopathology*; D004077:Digoxin; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D009318:Natriuresis; D009765:Obesity / Q000503:physiopathology*; D012503:Saponins
D001798:Blood Proteins; D002298:Cardenolides; D002301:Cardiac Glycosides; D012503:Saponins; C034504:digoxin-like factors; D004077:Digoxin